<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To investigate the expression of casein kinase 2β in <z:hpo ids='HP_0011459'>esophageal carcinoma</z:hpo> tissues and analyze its clinical significance </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: The expression of CK2β in a tissue chip containing 60 <z:mpath ids='MPATH_458'>normal</z:mpath> esophageal mucosa and 60 colorectal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> specimens were detected immunohistochemically </plain></SENT>
<SENT sid="2" pm="."><plain>Ten human <z:hpo ids='HP_0011459'>esophageal carcinoma</z:hpo> and adjacent <z:mpath ids='MPATH_458'>normal</z:mpath> tissues were examined for the expression of CK2β protein and <z:chebi fb="2" ids="33699">mRNA</z:chebi> using Western blotting and real-time quantitative PCR, respectively </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: A strong expression of CK2β was found in 85.71% of the <z:e sem="disease" ids="C0546837,C0014859" disease_type="Neoplastic Process" abbrv="">esophageal cancer</z:e> tissues; 1.79% of the <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> tissues were negative for CK2β expression, and 1.79% and 10.71% of the <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> tissues were weakly and moderately positive, respectively </plain></SENT>
<SENT sid="4" pm="."><plain>In the <z:mpath ids='MPATH_458'>normal</z:mpath> mucosal tissues, 96.67% of the tissues were negative for CK2β and 3.33% showed weak CK2β expression, showing a significant difference in the distribution of CK2β between <z:mpath ids='MPATH_458'>normal</z:mpath> and <z:hpo ids='HP_0011459'>esophageal carcinoma</z:hpo> tissues (P&lt;0.001) </plain></SENT>
<SENT sid="5" pm="."><plain>The expression level of CK2β in <z:e sem="disease" ids="C0546837,C0014859" disease_type="Neoplastic Process" abbrv="">esophageal cancers</z:e> was associated with the pathological stage (TNM) (P=0.010) </plain></SENT>
<SENT sid="6" pm="."><plain>Western blotting and real-time quantitative PCR also confirmed an increased CK2β expression in the <z:e sem="disease" ids="C0546837,C0014859" disease_type="Neoplastic Process" abbrv="">esophageal cancer</z:e> tissues </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSION: The high expression of protein kinase CK2β is closely related to the <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> of <z:e sem="disease" ids="C0546837,C0014859" disease_type="Neoplastic Process" abbrv="">esophageal cancer</z:e> </plain></SENT>
</text></document>